Gliflozin
Drugto study whether the use of gliflozin prevented diabetic complications
NCT Number: NCT06071208
Study of the possibility to prevent the development of Diabetic kidney disease in type 2 diabetic patients
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Study of the possible role of the SGLT2 inhibitors to prevent the development of frank type2 DM among prediabetic candidates.
Study of the possible role of the SGLT2 inhibitors to prevent the development of diabetic complications, namely diabetic kidney disease, diabetic retinopathy and neuropathy.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
to study whether the use of gliflozin prevented diabetic complications
Time frame: 5 years
glomerular filtration rate will be measured at the beginning of the study and at the end
Contact information is provided by the study sponsor or research team.
Ahmed Fayed, MD
CONTACT
Mohammed Hegazy, MD
CONTACT
Fayoum University
Other
The National Plan To Prevent Diabetic Kidney Disease Among Egyptians: A Prospective Multicenter Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.